Brief Title
Toripalimab With or Without Celecoxib as Neoadjuvant Therapy in Resectable dMMR/MSI-H Colon Cancer
Protocol ID
NCT03926338
Brief Summary
Conditions: Colon Cancer; MSI-H
Interventions: Drug: Neoadjuvant therapy with PD-1 inhibitor plus COX inhibitor; Drug: Neoadjuvant therapy with PD-1 inhibitor
Sponsor: Sun Yat-sen University
Recruiting
Interventions: Drug: Neoadjuvant therapy with PD-1 inhibitor plus COX inhibitor; Drug: Neoadjuvant therapy with PD-1 inhibitor
Sponsor: Sun Yat-sen University
Recruiting
Pub Date:
Wednesday, April 24, 2019 - 9:00am